New insights into lipid metabolism in non-insulin-dependent diabetes mellitus

Annals of Medicine

Volumn 28, Issue 4, 1996, Pages 335-340

  Taskinen, Marja Riitta ^a,b   Lahdenperä, Sanni ^a   Syvänne, Mikko ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Coronary heart disease risk; Fat intolerance; HDL; Small dense LDL; Triglyceride

Indexed keywords

INSULIN; LIPID;

ARTICLE; DYSLIPIDEMIA; HYPERTRIGLYCERIDEMIA; LIPID METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0029845226     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899608999090     Document Type: Article

References (27)

1. Taskinen M-R. Insulin resistance and lipoprotein metabolism. Curr Opin Lipidol 1995; 6: 153-60.
2. West KM, Ahuja MM, Bennett PH, et al. The role of circulating glucose and triglyceride concentrations and their interactions with other 'risk factors' as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care 1983; 6: 361-9.
3. Fontbonne A, Eschwege E, Gambien F, et al. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 1989; 32: 300-4.
4. Laakso M, Lehto S, Penttilä I, Pyörälä K. Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation 1993; 88: 1421-30.
5. Taskinen M-R. Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus. Diabetes 1992; 41 (Suppl 2): 12-7.
6. Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circulation 1979; 60: 473-85.
7. Karpe F, Hamsten A. Postprandial lipoprotein metabolism and atherosclerosis. Curr Opin Lipidol 1995; 6: 123-9.
8. Ebenbichler CF, Kirchmair R, Egger C, Patsch JR. Postprandial state and atherosclerosis. Curr Opin Lipidol 1995; 6: 286-90.
9. Karpe F, Steiner G, Uffelman K, Olivecrona T, Hamsten A. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 1994; 106: 83-97.
10. Lewis GF, O'Meara NM, Soltys PA, et al. Fasting hypertriglyceridemia in noninsulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities. J Clin Endocrinol Metab 1991; 72: 934-44.
11. Chen Y-D, Reaven GM. Intestinally derived lipoproteins: metabolism and clinical significance. Diabetes Metab Rev 1991; 7: 191-208.
12. Syvänne M, Hilden H, Taskinen M-R. Abnormal metabolism of postprandial lipoproteins in patients with noninsulin-dependent diabetes mellitus is not related to coronary artery disease. J Lipid Res 1994; 35: 15-26.
13. Curtin A, Deegan P, Owens D, Collins P, Johnson A, Tomkin GH. Alterations of apolipoprotein B-48 in the postprandial state in NIDDM. Diabetologia 1994; 37: 1259-64.
14. Cohn JS. Postprandial lipid metabolism. Curr Opin Lipidol 1994; 5: 185-90.
15. Mamo JCL. Atherosclerosis as a post-prandial disease. Endocrinol Metab 1995; 2: 229-44.
16. Kirchmair R, Ebenbichler CF, Patsch JR. Post-prandial lipaemia. Baillieres Clin Endocrinol Metab 1995; 9: 705-19.
17. Austin MA, Hokanson JE, Brunzell JD. Characterization of low-density lipoprotein subclasses: methodologic approaches and clinical relevance. Curr Opin Lipidol 1994; 5: 395-403.
18. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988; 260: 1917-21.
19. Krauss RM. Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk. Curr Opin Lipidol 1994; 5: 339-49.
20. Griffin BA, Freeman DJ, Tait GW, et al. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions, relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 1994; 106: 241-53.
21. Austin MA, King M-C, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype. Circulation 1990; 82: 495-506.
22. McNamara JR, Jenner JL, Liu Z, Wilson PWF, Schaefer EJ. Change in LDL particle size is associated with change in plasma triglyceride concentration. Arterioscler Thromb 1992; 12: 1284-90.
23. Lahdenperä S, Syvänne M, Kahri J, Taskinen M-R. Regulation of LDL particle size distribution in NIDDM and coronary disease: importance of serum triglycerides. Diabetologia 1996; 39: 453-61.
24. James RW, Pometta D. The distribution profiles of very low density and low density lipoproteins in poorly controlled male, type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991; 34: 246-52.
25. Owens D, McBrinn S, Collins P, Johnson A, Tomkin GH. The effect of low density lipoprotein composition on the regulation of cellular cholesterol synthesis: a comparison in diabetic and non-diabetic subjects. Acta Diabetol 1993; 30: 214-9.
26. Feingold KR, Grunfeld C, Pang M, Doerrler W, Krauss RM. LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes. Arterioscler Thromb 1992; 12: 1496-502.
27. Reaven GM, Chen Y-D, Jeppesen J, Krauss RM. Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. J Clin Invest 1993; 92: 141-6.